Arletta Lozanski
- Oncology top 10%
- Genetics top 2%
- Pathology and Forensic Medicine top 5%
- Immunology top 10%
- Molecular Biology
- Co-authors
- John C. ByrdShelly HeimfeldStanley R. RiddellKevin A. HayLaïla‐Aïcha HanafiSindhu CherianDavid G. MaloneyDaniel Li
- Topics
- Chronic Lymphocytic Leukemia Research (10 papers)Lymphoma Diagnosis and Treatment (9 papers)Immunodeficiency and Autoimmune Disorders (5 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Arletta Lozanski
14 papers receiving 833 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 451
- Genetics 441
- Pathology and Forensic Medicine 319
- Immunology 226
- Molecular Biology 206
Countries citing papers authored by Arletta Lozanski
This map shows the geographic impact of Arletta Lozanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arletta Lozanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arletta Lozanski more than expected).
Fields of papers citing papers by Arletta Lozanski
This network shows the impact of papers produced by Arletta Lozanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arletta Lozanski. The network helps show where Arletta Lozanski may publish in the future.
Co-authorship network of co-authors of Arletta Lozanski
This figure shows the co-authorship network connecting the top 25 collaborators of Arletta Lozanski. A scholar is included among the top collaborators of Arletta Lozanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arletta Lozanski. Arletta Lozanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 76 | |
| 6 | 1 | |
| 7 | Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinibbreakdown → | 485 |
| 8 | 7 | |
| 9 | 61 | |
| 10 | 131 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 46 | |
| 14 | 14 |
About Arletta Lozanski
Arletta Lozanski is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 14 papers that have together received 842 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). The work is most often cited by research in Genetics (441 citations), Pathology and Forensic Medicine (319 citations) and Oncology (451 citations). Arletta Lozanski has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include John C. Byrd, Shelly Heimfeld, Stanley R. Riddell, Kevin A. Hay, Laïla‐Aïcha Hanafi, Sindhu Cherian, David G. Maloney, Daniel Li, Cameron J. Turtle and Xueyan Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.